ID   SH2B3_RAT               Reviewed;         368 AA.
AC   P50745;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   24-JUL-2024, entry version 131.
DE   RecName: Full=SH2B adapter protein 3;
DE   AltName: Full=Lymphocyte adapter protein;
DE   AltName: Full=Lymphocyte-specific adapter protein Lnk;
DE   AltName: Full=Signal transduction protein Lnk;
GN   Name=Sh2b3; Synonyms=Lnk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LNK1; LNK2; LNK3 AND LNK4).
RC   STRAIN=Fischer; TISSUE=Lymph node;
RX   PubMed=8524815; DOI=10.1073/pnas.92.25.11618;
RA   Huang X., Li Y., Tanaka K., Moore K.G., Hayashi J.;
RT   "Cloning and characterization of Lnk, a signal transduction protein that
RT   links T-cell receptor activation signal to phospholipase C gamma 1, Grb2,
RT   and phosphatidylinositol 3-kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:11618-11622(1995).
CC   -!- FUNCTION: Links T-cell receptor activation signal to phospholipase C-
CC       gamma-1, GRB2 and phosphatidylinositol 3-kinase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=Lnk4;
CC         IsoId=P50745-1; Sequence=Displayed;
CC       Name=Lnk1;
CC         IsoId=P50745-2; Sequence=VSP_004310;
CC       Name=Lnk2;
CC         IsoId=P50745-3; Sequence=VSP_004308, VSP_004311;
CC       Name=Lnk3;
CC         IsoId=P50745-4; Sequence=VSP_004309, VSP_004311;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed by lymphocytes in lymph
CC       node and spleen.
CC   -!- PTM: Tyrosine-phosphorylated upon T-cell activation. The tyrosine
CC       phosphorylation site is multifunctional and may associate with the SH2
CC       domains of phospholipase C-gamma-1, GRB-2, and PI3-K upon T-cell
CC       receptor activation.
CC   -!- SIMILARITY: Belongs to the SH2B adapter family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U24655; AAC52351.1; -; mRNA.
DR   EMBL; U24654; AAC52350.1; -; mRNA.
DR   EMBL; U24653; AAC52349.1; -; mRNA.
DR   EMBL; U24652; AAC52348.1; -; mRNA.
DR   RefSeq; NP_113809.1; NM_031621.1.
DR   PDB; 8CZ9; X-ray; 1.65 A; A=111-220.
DR   PDBsum; 8CZ9; -.
DR   AlphaFoldDB; P50745; -.
DR   SMR; P50745; -.
DR   BioGRID; 248640; 2.
DR   STRING; 10116.ENSRNOP00000038125; -.
DR   PhosphoSitePlus; P50745; -.
DR   PaxDb; 10116-ENSRNOP00000066850; -.
DR   UCSC; RGD:68411; rat. [P50745-1]
DR   AGR; RGD:68411; -.
DR   RGD; 68411; Sh2b3.
DR   eggNOG; ENOG502QS89; Eukaryota.
DR   HOGENOM; CLU_014885_3_0_1; -.
DR   InParanoid; P50745; -.
DR   OrthoDB; 2995825at2759; -.
DR   PhylomeDB; P50745; -.
DR   PRO; PR:P50745; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042301; F:phosphate ion binding; IDA:RGD.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0030159; F:signaling receptor complex adaptor activity; ISO:RGD.
DR   GO; GO:0005173; F:stem cell factor receptor binding; ISO:RGD.
DR   GO; GO:1990869; P:cellular response to chemokine; ISO:RGD.
DR   GO; GO:0036016; P:cellular response to interleukin-3; ISO:RGD.
DR   GO; GO:0035162; P:embryonic hemopoiesis; ISO:RGD.
DR   GO; GO:0048821; P:erythrocyte development; ISO:RGD.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0035855; P:megakaryocyte development; ISO:RGD.
DR   GO; GO:0035702; P:monocyte homeostasis; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:1900235; P:negative regulation of Kit signaling pathway; ISO:RGD.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0090331; P:negative regulation of platelet aggregation; ISO:RGD.
DR   GO; GO:0046426; P:negative regulation of receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:1904893; P:negative regulation of receptor signaling pathway via STAT; ISO:RGD.
DR   GO; GO:0060761; P:negative regulation of response to cytokine stimulus; ISO:RGD.
DR   GO; GO:1903671; P:negative regulation of sprouting angiogenesis; IMP:RGD.
DR   GO; GO:0001780; P:neutrophil homeostasis; ISO:RGD.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; IMP:RGD.
DR   GO; GO:0038163; P:thrombopoietin-mediated signaling pathway; ISO:RGD.
DR   CDD; cd10412; SH2_SH2B3; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR030523; SH2B.
DR   InterPro; IPR035059; SH2B3_SH2.
DR   PANTHER; PTHR10872; SH2B ADAPTER PROTEIN; 1.
DR   PANTHER; PTHR10872:SF1; SH2B ADAPTER PROTEIN 3; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Phosphoprotein; Reference proteome;
KW   SH2 domain.
FT   CHAIN           1..368
FT                   /note="SH2B adapter protein 3"
FT                   /id="PRO_0000084456"
FT   DOMAIN          119..217
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   MOD_RES         356
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..95
FT                   /note="MAGRTQGKHRPRVRTCPSLVPFDNPCWPPSHQPLPLQVGAPGHRVTSFLSGR
FT                   AWPSYIPKGKHGLPGPRYVPDPWSLGVLGHVAPLRVTTTIFLP -> MPDNLYTFVLKV
FT                   QGQTDIIFEVGDEQQLNSWLAELRASTGLGLEHLDTELPLSLVAEPGPAISPRGSTDSL
FT                   DQ (in isoform Lnk2)"
FT                   /evidence="ECO:0000303|PubMed:8524815"
FT                   /id="VSP_004308"
FT   VAR_SEQ         14..38
FT                   /note="Missing (in isoform Lnk3)"
FT                   /evidence="ECO:0000303|PubMed:8524815"
FT                   /id="VSP_004309"
FT   VAR_SEQ         225..278
FT                   /note="Missing (in isoform Lnk1)"
FT                   /evidence="ECO:0000303|PubMed:8524815"
FT                   /id="VSP_004310"
FT   VAR_SEQ         226..262
FT                   /note="Missing (in isoform Lnk2 and isoform Lnk3)"
FT                   /evidence="ECO:0000303|PubMed:8524815"
FT                   /id="VSP_004311"
SQ   SEQUENCE   368 AA;  40432 MW;  624CC2ABA0332C87 CRC64;
     MAGRTQGKHR PRVRTCPSLV PFDNPCWPPS HQPLPLQVGA PGHRVTSFLS GRAWPSYIPK
     GKHGLPGPRY VPDPWSLGVL GHVAPLRVTT TIFLPGASPG VMLDPACQKT DHFLSCYPWF
     HGPISRVRAA QLVQLQGPDA HGVFLVRQSE SRRGEYVLTF NLQGRAKHLR LVLTERGQCR
     VQHLHFPSVV DMLRHFQRSP IPLECGAACD VRLSGYVVVV SQAPGRKPKV VSRGGVTAST
     ARTKLPSWLR LLHGVIHVIS PGSSNTVLFP FSLPHWDSEL GHPHLSSAGC PPGHGAEALR
     GQVTPPEQIF HLVPSPEELA NSLRQLELES VSSARDSDYE MDSSSRSHLR AIDNQYTPLS
     QLCREANL
//
